TERN — TERNS PHARMACEUTICALS INC

Ownership history in Logos Global Management LP  ·  1 quarter on record

This page tracks every 13F SEC filing in which Logos Global Management LP reported a position in TERNS PHARMACEUTICALS INC (TERN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.83% (2025 Q4)
Avg. % of fund
1.83%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 750,000 — — 1.83% $30.3M $40.40
% of Fund (quarterly)    TERN price (monthly, adj. close)

Other funds also holding TERN

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 23.9% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 17.48% Vivo Capital, LLC 3Y 7Y 13.96% SUPERSTRING CAPITAL MANAGEMENT LP 9.6% Vestal Point Capital, LP 6.18% Ikarian Capital, LLC 3Y 5.04% Monashee Investment Management LLC 3Y 7Y 4.49% First Turn Management, LLC 4.03% Commodore Capital LP 3Y 3.97% STEMPOINT CAPITAL LP 2.97%
← Back to Logos Global Management LP Holdings